Clinical Trial Update: A Study of BL-M02D1 in Patients With Locally Advanced or Metastatic Triple Negative Breast Cancer or Other Solid Tumors [Phase 1]

View source ↗

Summary

This is a Phase 1 clinical trial update for BL-M02D1 in patients with locally advanced or metastatic triple-negative breast cancer and other solid tumors; the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• BL-M02D1

Snippet

Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. | Conditions: Breast Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING